Sunday, March 4, 2012

Ranexa label.(RXs)(CV Therapeutics Inc. get approval from FDA)(Brief article)

CV Therapeutics Inc. says that the FDA has approved its drug Ranexa as a primary treatment for chronic angina. According to the revised label, the medication may be …

No comments:

Post a Comment